The global digital pathology market is anticipated to reach a valuation of US$ 7,035.8 million in 2023, driven by shift towards personalized medicine. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 13.5% between 2023 and 2033, and reaching a total valuation of approximately US$ 24,961.8 million by 2033.

A major factor contributing to the growth of the market is the integration of AI and deep learning algorithms with digital pathology systems, which can automate image analysis, enhance diagnostic accuracy, and provide predictive insights, making pathology practices more efficient and precise.

Request A Sample Copy of This Report!

Digital pathology facilitates the creation of virtual tumor boards, where multidisciplinary teams of healthcare professionals can collaborate on complex cases, improving treatment planning and outcomes. Research institutions and biotechnology companies are increasingly using digital pathology for preclinical and clinical research, contributing to the market's growth.

Developing industry standards and ensuring interoperability between different digital pathology solutions can drive adoption by reducing compatibility issues and increasing ease of use. Giving patients access to their pathology reports and images through secure online portals can enhance patient engagement and understanding of their health conditions.

Implementing blockchain technology can enhance the security and integrity of digital pathology data, addressing concerns related to data privacy and tampering. Collaborations between international health organizations and governments to improve healthcare infrastructure and access to pathology services in low-resource regions can open up new markets for digital pathology solutions.

Key Takeaways from the Market Study:

  • Global digital pathology market was valued at US$ 6,199.0 million by 2022-end.
  • From 2018 to 2022, the market demand expanded at a CAGR of 10.6%.
  • The market in India is expected to expand at a CAGR of 13.4% through 2033.
  • By end-user, the pharmaceutical and biotechnology companies segment to expand at a CAGR of 13.2% through 2033.
  • From 2023 to 2033, digital pathology market is expected to flourish at a CAGR of 13.5%.
  • By 2033, the market value of digital pathology is expected to reach US$ 24,961.8 million.

“Beyond traditional histopathology, digital pathology is finding applications in fields like dermatopathology, veterinary pathology, and oral pathology, broadening its market scope”, remarks an FMI analyst.

Competitive Landscape:

Prominent players in the digital pathology market are Danaher Corporation, F. Hoffmann-La Roche AG, Huron Technologies International Inc., Koninklijke Philips N.V., Olympus Corporation, Hamamatsu Photonics K.K., Carl Zeiss AG, Nikon Corporation, 3DHISTECH Ltd., Hologic Inc., PerkinElmer, Inc., Visiopharm, OptraSCAN, Inc., Inspirata, Inc., and Sectra AB., among others.

Recent Developments:

  • In 2023, Philips Healthcare announced the launch of its new digital pathology solution, the Philips IntelliSite Pathology Solution. The Philips IntelliSite Pathology Solution is a comprehensive digital pathology solution that offers a wide range of features, including whole slide imaging, image analysis, and telepathology.
  • In 2022, PerkinElmer announced the launch of its new digital pathology software, the PerkinElmer Pathology Informatics Platform. The PerkinElmer Pathology Informatics Platform is a cloud-based digital pathology platform that offers a wide range of features, including whole slide imaging, image analysis, and telepathology.

Segmentation Analysis of the Digital Pathology Market:

By Product Type:

  • Digital Pathology Equipment
    • Whole Slide Scanners
      • Brightfield Slide Scanners
      • Fluorescence Slide Scanners
      • Combination Slide Scanners
    • Clinical Microscope
    • Tissue Microarrays
  • Digital Pathology Software
    • Image Viewing and Analysis Software
      • On-premise
      • Cloud-based
  • Digital Pathology Information Systems
    • On-premise
    • Cloud-based
  • Digital Pathology Services
    • Installation and Integration Services
    • Consulting Services
    • Maintenance and Validation Services

By Application:

  • Clinical Pathology
  • Molecular Diagnostics
  • Basic & Applied Research
  • Drug Development
  • Others

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa